"Reconsidering Chemotherapy for Terminal Cancer: Should Doctors Say No?"

Oncologists often face the dilemma of whether to continue offering chemotherapy to cancer patients, even when the chances of success are slim. Data shows that a significant percentage of patients receive chemotherapy close to the end of life, despite potential negative impacts on quality and duration of life. While optimism and the desire to help patients may drive this practice, it raises ethical questions about the benefits and harms of such treatments. Balancing hope with realistic expectations, open communication, and consideration of palliative care are crucial in guiding patients and their families through these difficult decisions.